Hybrid BCAA 1000mg – BCAAs Amino Acids Supplements - 2:1:1 L-Leucine, L-Isoleucine and L-Valine – Non-GMO, Vegan - 120 Servings
- Non GMO Vegan formula, 1000mg per serving Tablets; PURE branched chain amino acids (no artificial sweetners or coloring); 120 Servings, Made in the USA in a cGMP certified facility.
- BCAAs Amino Acids: BCAA tablets contain a 2:1:1 ratio of L-Leucine to L-Isoleucine and L-Valine.
- Muscle Support and RECOVERY, Recharge & Refuel, Increased Power & Strength, Endurance and Boost Performance with Pure BCAAs (also known as BCC amiino acids or BCCA); the optimal amino tablets.
- NSF Certified, high QUALITY Branched Chain Amino Acids, No Crash, No jitters, No Negative Side Effects
- Your sugar free pre workout and pre workout without creatine. A great pre workout women as well as a preworkout for men; just pure BCAAs amino acids powder in every tablet. (Our BCAA pills are as effective as the BCAA capsules)
Önemli bilgi
Malzemeler
BCAA (Branch Chain Amino Acids): L-Leucine, L-Isoleucine, L-Valine
Yol Tarifi
1 tablet taken preferable with water before and/or after training or as directed by a healthcare professional
Yasal Feragatname
Beslenme takviyeleri ile ilgili açıklamalar FDA tarafından değerlendirilmemiştir ve herhangi bir hastalık veya sağlık durumunu teşhis etmek, tedavi etmek veya önlemek amaçlanmamıştır.
Ürün Boyutu
2.5 x 2.5 x 5 inç; 9 yorum
Specifications
| Ürün Faydaları | Pre Workout, Post Workout |
| Malzemeler | L-Valine, L-Isoleucine, BCAA (branch Chain replicas): L-Leucine |
| Expiry Date | 2026 Aralık |
| Diyet Tipi | Vegan Vegan |
| L x x x x | 2.5 x 2.5 x 5 Inches |
| Özel Malzemeler | Bcaas |
| Flavor | Selam |
| Form | Tablet Tablet |
| Unit Count | 120.00 Count |
| Ürün Türü | Beslenme Tamamı |
| Primary Supplement Type | Bcaas |
| Ağırlık | 9 Eyunces |
| Brand Brand Brand | Hybrid Hybrid Hybrid Hybrid |
| Tags | |
|---|---|
| Tags | |
Your Dynamic Snippet will be displayed here...
This message is displayed because youy did not provide both a filter and a template to use.









